行情

PRPH

PRPH

ProPhase实验室
NASDAQ

实时行情|Nasdaq Last Sale

7.03
+0.51
+7.82%
已收盘, 16:00 05/13 EDT
开盘
7.40
昨收
6.52
最高
7.70
最低
7.03
成交量
9.46万
成交额
40.35万
52周最高
8.58
52周最低
4.238
市值
1.09亿
市盈率(TTM)
86.68
分时
5日
1月
3月
1年
5年
ProPhase Labs, Inc. (PRPH) Tops Q1 Earnings and Revenue Estimates
ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of 74.36% and 95.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 2天前
Recap: ProPhase Labs Q1 Earnings
  ProPhase Labs (NASDAQ:PRPH) reported its Q1 earnings results on Friday, May 13, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Benzinga · 2天前
ProPhase Labs GAAP EPS of $0.81 beats by $0.34, revenue of $47.5M beats by $15.45M
ProPhase Labs press release (NASDAQ:PRPH): Q1 GAAP EPS of $0.81 beats by $0.34. Revenue of $47.5M (+210.5% Y/Y) beats by $15.45M. “We expect Q2 2022 to continue to produce strong
Seekingalpha · 3天前
ProPhase Labs Q1 EPS $0.68 Beats $0.38 Estimate, Sales $47.50M Beat $24.31M Estimate
ProPhase Labs (NASDAQ:PRPH) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.38 by 78.95 percent. This is a 151.85 percent increase over earnings of $0.27 per share from the
Benzinga · 3天前
BRIEF-ProPhase Labs Reports Q1 EPS $0.81
reuters.com · 3天前
ProPhase Labs Announces Record First Quarter 2022 Financial Results
Record Net Revenues of $47.5 Million, Up 211% Year-over-Year Record Net Income of $12.5 Million, Increasing 1082% Year-over-Year Announces Special Cash Dividend of $0.30 per share Management to Host Conference Call Today at 11:00 a.m. ET GARDEN CITY, NY, M...
GlobeNewswire · 3天前
-- Earnings Flash (PRPH) PROPHASE LABS Reports Q1 Revenue $47.5M, vs. Street Est of $32.1M
MT Newswires · 3天前
Preview: ProPhase Labs's Earnings
ProPhase Labs (NASDAQ:PRPH) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that ProPhase Labs will report an earnings per share (EPS) of $0.38.
Benzinga · 3天前
更多
暂无数据
了解PRPH最新的财务预测,通过PRPH每股收益,每股净资产,每股现金流等数据分析ProPhase实验室近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
66.67%买入
33.33%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测PRPH价格均价为11.00,最高价位16.00,最低价为5.00。
最高16.00
均价11.00
最低5.00
现价7.03
EPS
实际EPS
预期EPS
0.000.270.530.80
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
机构持股
总机构数: 30
机构持股: 154.74万
持股比例: 9.99%
总股本: 1,548.59万
类型机构数股数
增持
5
7.22万
建仓
10
14.33万
减持
4
1.51万
平仓
6
33.77万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
食品加工
+1.66%
食品和烟类
+1.76%
高管信息
Chairman/Chief Executive Officer/Director
Ted Karkus
Chief Financial Officer
Monica Brady
Chief Operating Officer/Executive Vice President
Jason Karkus
Chief Operating Officer/Executive Vice President
Alice Lioi
Chief Investment Officer
Sergio Miralles
Other
Sam Beeler
Independent Director
Jason Barr
Independent Director
Louis Gleckel
Independent Director
Warren Hirsch
暂无数据
暂无数据
PRPH 简况
Prephase Labs,Inc.是一家医疗科技公司。该公司通过两个部门运营:消费品和诊断服务。消费品分部在美国从事非处方(OTC)消费保健品和膳食补充剂的研究、开发、制造、分销、营销和销售。诊断服务分部为美国的一系列客户提供新冠病毒-19诊断信息服务,包括健康计划、第三方付款人和政府组织。该公司还从事开发和分销TK补充剂品牌的OTC膳食补充剂产品线。TK补充剂产品线提供两种男性健康产品,包括用于性健康的Legendz XL和Triple Edge XL,一种能量助推器加睾酮支持。

微牛提供ProPhase Labs Inc(NASDAQ-PRPH)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的PRPH股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易PRPH股票基本功能。